Molecular Surveillance of Plasmodium vivax and Plasmodium falciparum Drug Resistance Genes in the Republic of Korea: 2022–2025
Pathogens · 08.05.2026 · 15 (5) · 508
DOI: 10.3390/pathogens15050508 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, online erschienen am 08.05.2026. Verfasst von Haneul Jung und 6 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vectors and Parasitic Diseases, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju…. Hauptthemen laut MEDLINE: Plasmodium falciparum, Drug Resistance, Plasmodium vivax, Antimalarials. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korea Disease Control and Prevention Agency.
Abstract (Originalsprache)
In the Republic of Korea (ROK), chloroquine is the first-line treatment for Plasmodium vivax (P. vivax), and primaquine is also prescribed to prevent relapse. For Plasmodium falciparum (P. falciparum), atovaquone-proguanil, pyronaridine-artesunate, and mefloquine are recommended. This study monitored drug resistance genes in blood samples collected from patients with P. vivax (soldiers, relapsed, and imported) and P. falciparum (soldiers and civilians) between 2022 and 2025. In P. vivax, several Pvmdr-1 mutations showed high prevalence, with S515R, G698S, L845F, M908L, T958M, and F1076L observed in nearly all isolates, while T529 and E1233 mutation showed moderate prevalence. S513R, Y541C, A829V, and S1358 mutation were occasionally identified, all of which were imported or soldiers receiving prophylactic chemotherapy. Significant differences in mutation prevalence were identified among groups (p < 0.05). However, no significant temporal trends were observed. In P. falciparum, the Y184F mutation in Pfmdr-1 was highly prevalent, and A675V mutation in PfK13 was detected only in soldiers. Group comparisons revealed significant differences (p < 0.05), whereas temporal trends were not observed. Because drug resistance gene mutations can be closely linked to treatment, surveillance of drug resistance genes is expected to contribute to malaria eradication in the ROK through providing basic information related to treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Vectors and Parasitic Diseases, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju 28159, Chungcheongbuk-do, Republic of Korea.
- Division of Zoonotic and Vector Borne Disease Control, Korea Disease Control and Prevention Agency, 187 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju 28159, Chungcheongbuk-do, Republic of Korea.
- Division of Laboratory Diagnosis and Analysis, Capital Regional Center for Disease Control and Prevention, Korea Disease Control and Prevention Agency, 131 Yeongjong Haeannam-ro 321beon-gil, Jung-gu, Incheon 22382, Repu…
ORCID-Profile: Haneul Jung, Hyun-Il Shin, Bora Ku, Myoung-Ro Lee, Jung-Won Ju, Hee-Il Lee
Förderung
- Korea Disease Control and Prevention Agency
Zitieren
APA
Jung, H., Shin, H. I., Ku, B., Park, E., Lee, M. R., Ju, J. W., & Lee, H. I. (2026). Molecular Surveillance of Plasmodium vivax and Plasmodium falciparum Drug Resistance Genes in the Republic of Korea: 2022–2025. Pathogens, 15(5), 508. https://doi.org/10.3390/pathogens15050508
Vancouver
Jung H, Shin HI, Ku B, Park E, Lee MR, Ju JW, et al. Molecular Surveillance of Plasmodium vivax and Plasmodium falciparum Drug Resistance Genes in the Republic of Korea: 2022–2025. Pathogens. 2026;15(5):508. doi:10.3390/pathogens15050508
BibTeX
@article{Jung2026,
author = {Jung, Haneul and Shin, Hyun-Il and Ku, Bora and Park, Esther and Lee, Myoung-Ro and Ju, Jung-Won and Lee, Hee-Il},
title = {Molecular Surveillance of Plasmodium vivax and Plasmodium falciparum Drug Resistance Genes in the Republic of Korea: 2022–2025},
journal = {Pathogens},
year = {2026},
volume = {15},
number = {5},
pages = {508},
doi = {10.3390/pathogens15050508}
}
EUVIMED